| Date | Title | Description | Source |
| 13.03.2024 | PepGen to Participate in Upcoming Investor Conferences | - | globenewsw... |
| 06.03.2024 | PepGen Reports Fourth Quarter and Full Year 2023 Financial R... | - | globenewsw... |
| 07.02.2024 | PepGen Announces Pricing of $80.1 Million Underwritten Offer... | - | globenewsw... |
| 10.08.2021 | Digital health news, funding roundup in the prior week; Augu... | PepGen raised $112.5M; Lucid Lane landed $16M; Kensho Health secured $3.5M; DynamiCare Health picks
... | vator.tv/n... |
| 05.08.2021 | PepGen raises $113M to challenge Sarepta in DMD, build neuro... | PepGen has raised $112.5 million to take a treatment for Duchenne muscular dystrophy (DMD) into the ... | fiercebiot... |
| 05.08.2021 | Back from the dead, Brandless moves into the creator economy... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 05.08.2021 | PepGen Announces Closing of $112.5 Million Crossover Financi... | BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) -- PepGen, Inc., a company developing next-generation oligonu... | marketscre... |
| 05.08.2021 | Back from the dead, Brandless moves into the creator economy... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 05.08.2021 | PepGen raises $113M to challenge Sarepta in DMD, build neuro... | Great Duchenne muscular dystrophy (DMD) therapies are just not getting enough medicine into the cell... | fiercebiot... |
| 19.04.2021 | PepGen to Present a CureDuchenne Webinar on Unlocking the Po... | | prnewswire... |
| 23.03.2021 | PepGen to Present at Stifel's 3rd Annual CNS Day | | prnewswire... |
| 15.03.2021 | PepGen to Present Late-Breaking Data from Novel Enhanced Del... | | prnewswire... |
| 26.02.2021 | PepGen Announces Formation of Scientific Advisory Board | | prnewswire... |
| 04.02.2021 | PepGen Announces Appointment of James McArthur, Ph.D., as Pr... | | prnewswire... |
| 09.12.2020 | RA Capital Management Leads $45M Series A Financing for PepG... | BOSTON and OXFORD, United Kingdom, Dec. 09, 2020 (GLOBE NEWSWIRE) -- PepGen, a therapeutics company ... | marketscre... |
| - | PepGen IPO nabs $108M for muscular dystrophy drug with poten... | The rare disorder Duchenne muscular dystrophy is treated with genetic medicines that get skeletal mu... | medcitynew... |
